
384: Live from the JP Morgan conference, a sit-down with Novo Nordisk's CEO and VC Bob Nelsen
The Readout Loud
00:00
R&D, BD activity, and external partnering
Mike defends Novo's dealmaking, highlights 100+ BD transactions, and pledges greater outward engagement.
Play episode from 10:13
Transcript


